This is the authors' abstract. We don't add key points for this paper.
S4. Targeting Polθ + PARP and Polθ + RAD52 induced dual synthetic lethality against HR -deficient MPN cells.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sullivan-Reed et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: